Search Results - "Caldarelli, Ilaria"

Refine Results
  1. 1

    Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases by Stampone, Emanuela, Caldarelli, Ilaria, Zullo, Alberto, Bencivenga, Debora, Mancini, Francesco Paolo, Della Ragione, Fulvio, Borriello, Adriana

    “…The gene encodes the p57 protein which has been identified as the third member of the CIP/Kip family, also including p27 and p21 . In analogy with these…”
    Get full text
    Journal Article
  2. 2

    Resveratrol and cancer treatment: is hormesis a yet unsolved matter? by Borriello, Adriana, Bencivenga, Debora, Caldarelli, Ilaria, Tramontano, Annunziata, Borgia, Alessia, Pirozzi, Anna Virginia Adriana, Oliva, Adriana, Della Ragione, Fulvio

    Published in Current pharmaceutical design (2013)
    “…Plants produce many low molecular mass natural compounds endowed with biological activity. Among them, resveratrol (3,5,4'-trihydroxystilbene) has been…”
    Get more information
    Journal Article
  3. 3

    The tyrosine kinase inhibitor dasatinib induces a marked adipogenic differentiation of human multipotent mesenchymal stromal cells by Borriello, Adriana, Caldarelli, Ilaria, Basile, Maria Assunta, Bencivenga, Debora, Tramontano, Annunziata, Perrotta, Silverio, Della Ragione, Fulvio, Oliva, Adriana

    Published in PloS one (02-12-2011)
    “…The introduction of specific BCR-ABL inhibitors in chronic myelogenous leukemia therapy has entirely mutated the prognosis of this hematologic cancer from…”
    Get full text
    Journal Article
  4. 4
  5. 5

    p57Kip2 and Cancer: Time for a Critical Appraisal by Borriello, Adriana, Caldarelli, Ilaria, Bencivenga, Debora, Criscuolo, Maria, Cucciolla, Valeria, Tramontano, Annunziata, Oliva, Adriana, Perrotta, Silverio, Della Ragione, Fulvio

    Published in Molecular cancer research (01-10-2011)
    “…Abstract p57Kip2 is a cyclin-dependent kinase inhibitor belonging to the Cip/Kip family, which also includes p21Cip1 and p27Kip1. So far, p57Kip2 is the…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Resveratrol: from basic studies to bedside by Borriello, Adriana, Bencivenga, Debora, Caldarelli, Ilaria, Tramontano, Annunziata, Borgia, Alessia, Zappia, Vincenzo, Della Ragione, Fulvio

    Published in Cancer treatment and research (01-01-2014)
    “…Plants produce a remarkable amount of low molecular mass natural products endowed with a large array of pivotal biological activities. Among these molecules,…”
    Get more information
    Journal Article
  9. 9

    p57(Kip2) and cancer: time for a critical appraisal by Borriello, Adriana, Caldarelli, Ilaria, Bencivenga, Debora, Criscuolo, Maria, Cucciolla, Valeria, Tramontano, Annunziata, Oliva, Adriana, Perrotta, Silverio, Della Ragione, Fulvio

    Published in Molecular cancer research (01-10-2011)
    “…p57(Kip2) is a cyclin-dependent kinase inhibitor belonging to the Cip/Kip family, which also includes p21(Cip1) and p27(Kip1). So far, p57(Kip2) is the…”
    Get full text
    Journal Article
  10. 10

    p27Kip1and human cancers: A reappraisal of a still enigmatic protein by Bencivenga, Debora, Caldarelli, Ilaria, Stampone, Emanuela, Mancini, Francesco Paolo, Balestrieri, Maria Luisa, Fulvio Della Ragione, Borriello, Adriana

    Published in Cancer letters (10-09-2017)
    “…p27Kip1is a cell cycle regulator firstly identified as a cyclin-dependent kinase inhibitor. For a long time, its function has been associated to cell cycle…”
    Get full text
    Journal Article
  11. 11

    p27 Kip1 and human cancers: A reappraisal of a still enigmatic protein by Bencivenga, Debora, Caldarelli, Ilaria, Stampone, Emanuela, Mancini, Francesco Paolo, Balestrieri, Maria Luisa, Della Ragione, Fulvio, Borriello, Adriana

    Published in Cancer letters (10-09-2017)
    “…p27 is a cell cycle regulator firstly identified as a cyclin-dependent kinase inhibitor. For a long time, its function has been associated to cell cycle…”
    Get full text
    Journal Article
  12. 12

    p27Kip1 and human cancers: A reappraisal of a still enigmatic protein by Bencivenga, Debora, Caldarelli, Ilaria, Stampone, Emanuela, Mancini, Francesco Paolo, Balestrieri, Maria Luisa, Della Ragione, Fulvio, Borriello, Adriana

    Published in Cancer letters (10-09-2017)
    “…p27Kip1 is a cell cycle regulator firstly identified as a cyclin-dependent kinase inhibitor. For a long time, its function has been associated to cell cycle…”
    Get full text
    Journal Article
  13. 13

    Tyrosine kinase inhibitors and mesenchymal stromal cells: effects on self-renewal, commitment and functions by Borriello, Adriana, Caldarelli, Ilaria, Bencivenga, Debora, Stampone, Emanuela, Perrotta, Silverio, Oliva, Adriana, Della Ragione, Fulvio

    Published in Oncotarget (17-01-2017)
    “…The hope of selectively targeting cancer cells by therapy and eradicating definitively malignancies is based on the identification of pathways or metabolisms…”
    Get full text
    Journal Article
  14. 14
  15. 15

    p27Kip1 serine 10 phosphorylation determines its metabolism and interaction with cyclin-dependent kinases by Bencivenga, Debora, Tramontano, Annunziata, Borgia, Alessia, Negri, Aide, Caldarelli, Ilaria, Oliva, Adriana, Perrotta, Silverio, Della Ragione, Fulvio, Borriello, Adriana

    Published in Cell cycle (Georgetown, Tex.) (01-12-2014)
    “…p27Kip1 is a critical modulator of cell proliferation by controlling assembly, localization and activity of cyclin-dependent kinase (CDK). p27Kip1 also plays…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Transferrin‐immune complex disease: A potentially overlooked gammopathy mediated by IgM and IgG by Forni, Gian Luca, Pinto, Valeria, Musso, Marco, Mori, Marco, Girelli, Domenico, Caldarelli, Ilaria, Borriello, Adriana, Ragione, Fulvio Della

    Published in American journal of hematology (01-12-2013)
    “…The combination of marked hypersideremia, hypertransferrinemia, and monoclonal gammopathy of underdetermined significance (MGUS) should alert clinicians to the…”
    Get full text
    Journal Article
  18. 18

    Cystatin B and its EPM1 mutants are polymeric and aggregate prone in vivo by Cipollini, Elena, Riccio, Massimo, Di Giaimo, Rossella, Dal Piaz, Fabrizio, Pulice, Giuseppe, Catania, Sandra, Caldarelli, Ilaria, Dembic, Maja, Santi, Spartaco, Melli, Marialuisa

    Published in Biochimica et biophysica acta (01-02-2008)
    “…Progressive myoclonus epilepsy type 1 (EPM1) is a neurodegenerative disease correlating with mutations of the cystatin B gene. Cystatin B is described as a…”
    Get full text
    Journal Article
  19. 19
  20. 20

    p57Kip2 is a downstream effector of BCR―ABL kinase inhibitors in chronic myelogenous leukemia cells by BORRIELLO, Adriana, CALDARELLI, Ilaria, BENCIVENGA, Debora, CUCCIOLLA, Valeria, OLIVA, Adriana, USALA, Emilio, DANISE, Paolo, RONZONI, Luisa, PERROTTA, Silverio, RAGIONE, Fulvio Della

    Published in Carcinogenesis (New York) (2011)
    “…Chronic myelogenous leukemia (CML) is characterized by the expression of BCR-ABL tyrosine kinase, which results in increased cell proliferation and inhibition…”
    Get full text
    Journal Article